Bicocca Open Archive

Logo unimib boa
ALIBERTI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.928
EU - Europa 3.485
AS - Asia 1.522
SA - Sud America 24
OC - Oceania 12
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 13.983
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.756
CN - Cina 716
DE - Germania 652
SE - Svezia 580
UA - Ucraina 505
IE - Irlanda 469
RU - Federazione Russa 375
SG - Singapore 366
IT - Italia 351
HK - Hong Kong 254
CA - Canada 170
GB - Regno Unito 164
FI - Finlandia 122
AT - Austria 105
VN - Vietnam 70
FR - Francia 63
IN - India 43
NL - Olanda 27
CZ - Repubblica Ceca 24
ID - Indonesia 23
BR - Brasile 18
DK - Danimarca 17
TR - Turchia 17
BE - Belgio 13
JP - Giappone 10
AU - Australia 6
NZ - Nuova Zelanda 6
IR - Iran 5
BG - Bulgaria 4
EG - Egitto 4
ES - Italia 4
TH - Thailandia 4
LB - Libano 3
CO - Colombia 2
EU - Europa 2
GR - Grecia 2
IQ - Iraq 2
KR - Corea 2
MX - Messico 2
PE - Perù 2
PT - Portogallo 2
SC - Seychelles 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
CH - Svizzera 1
CM - Camerun 1
EC - Ecuador 1
KH - Cambogia 1
KZ - Kazakistan 1
LT - Lituania 1
MD - Moldavia 1
MU - Mauritius 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
PL - Polonia 1
RO - Romania 1
TJ - Tagikistan 1
TW - Taiwan 1
VE - Venezuela 1
Totale 13.983
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.381
Woodbridge 1.161
Fairfield 865
Houston 766
Jacksonville 565
Dublin 458
Chandler 456
Ashburn 413
Wilmington 363
Seattle 351
Dearborn 346
Cambridge 302
Singapore 291
Hong Kong 253
Frankfurt am Main 238
Princeton 225
New York 191
Nanjing 119
Altamura 108
Hangzhou 107
Santa Clara 103
Beijing 101
Lachine 97
Milan 96
Lawrence 95
Vienna 94
Shanghai 90
Nanchang 46
San Diego 39
Shenyang 32
Ottawa 31
Dong Ket 30
Hebei 29
Jiaxing 26
Brno 23
Andover 22
Norwalk 22
Toronto 22
Tianjin 21
Falls Church 20
Helsinki 20
Jakarta 20
Guangzhou 19
Jinan 19
Munich 17
Ningbo 17
Mountain View 16
London 15
Changsha 14
Fremont 14
Huizen 14
Boardman 13
Brussels 11
Hefei 10
Kunming 10
Chicago 9
Zhengzhou 9
Beauharnois 8
Lissone 8
Moscow 8
Kilburn 7
San Mateo 6
Edmonton 5
Lappeenranta 5
Montréal 5
Redmond 5
Rome 5
Sacramento 5
Taizhou 5
Turin 5
Bangkok 4
Nuremberg 4
Nürnberg 4
Phoenix 4
San Francisco 4
University Park 4
Ankara 3
Auburn Hills 3
Auckland 3
Bari 3
Campodarsego 3
Cincinnati 3
Dallas 3
Groningen 3
Hanoi 3
Jaipur 3
Kiev 3
Laurel 3
Leawood 3
Linköping 3
Los Angeles 3
Messina 3
Monmouth Junction 3
Sofia 3
Virginia Beach 3
Zanjan 3
Adelaide 2
Baotou 2
Basra 2
Beirut 2
Totale 10.414
Salva come PNG Salva come JPEG
Nome #
Characterizing non-tuberculous mycobacteria infection in bronchiectasis 294
Impact of age and comorbidity on cause and outcome in community-acquired pneumonia 243
Dyspnea in crackling lungs 218
Delirium symptoms during hospitalization predict long-term mortality in patients with severe pneumonia 209
Impact of traffic-related air pollution on pulmonary oxidative stress 204
Influenza A/H1N1 severe pneumonia: Novel morphocytological findings in bronchoalveolar lavage 199
Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases 188
Cardiovascular autonomic alterations in hospitalized patients with community-acquired pneumonia 186
Diaphragm ultrasonography in the management of patients with amyotrophic lateral sclerosis 185
Clinical phenotypes in adult patients with bronchiectasis 182
Positive end expiratory pressure in acute hypoxemic respiratory failure due to community acquired pneumonia: Do we need a personalized approach? 180
A 61-year-old female with chronic cough and purulent sputum 177
Mixed community-acquired lower respiratory tract infections 172
Multidimensional severity assessment in bronchiectasis: An analysis of seven European cohorts 172
A 13-year-old female with shortness of breath and pleuritic chest pain 171
Non-tuberculous mycobacteria pulmonary disease: an integrated approach beyond antibiotics 170
Prulifloxacin: A brief review of its potential in the treatment of acute exacerbation of chronic bronchitis 165
Hospital admission decision for patients with community-acquired pneumonia 163
Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity 163
Mortality in acute cardiogenic pulmonary edema treated with continuous positive airway pressure 158
The role of lung ultrasound in the diagnosis and follow-up of community-acquired pneumonia 153
Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: A multinational point prevalence study of hospitalised patients 153
Chlamydia pneumoniae and acute aortic syndrome: A call for a multi-institutional study 152
Early administration of the first antimicrobials should be considered a marker of optimal care of patients with community-acquired pneumonia rather than a predictor of outcomes 149
The management of community-acquired pneumonia in the elderly 147
Helmet CPAP vs. oxygen therapy in severe hypoxemic respiratory failure due to pneumonia 146
Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study 143
Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia 141
Microbiological Diagnosis and Antibiotic Therapy in Patients with Community-Acquired Pneumonia and Acute COPD Exacerbation in Daily Clinical Practice: Comparison to Current Guidelines 140
Strategic targets of essential host-pathogen interactions 139
Non-invasive continuous positive airway pressure in monolateral lung transplant patient with pneumonia and IPF 139
Contrasting Inflammatory Responses in Severe and Non-severe Community-acquired Pneumonia 139
Pneumonia: how important are local epidemiology and smoking habits? 138
Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study 138
Phenotyping in Bronchiectasis: Are we moving towards a personalized medicine? 138
Nontuberculous Mycobacteria in Noncystic Fibrosis Bronchiectasis 137
Compliance with anti-H1N1 vaccine among healthcare workers and general population 136
Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study 135
Criteria for clinical stability in hospitalised patients with community-acquired pneumonia 133
Serum and exhaled breath condensate inflammatory cytokines in community-acquired pneumonia: a prospective cohort study 133
The effectiveness of the polysaccharide pneumococcal vaccine for the prevention of hospitalizations due to Streptococcus pneumoniae community-acquired pneumonia in the elderly differs between the sexes: results from the Community-Acquired Pneumonia Organization (CAPO) international cohort study 133
Should health care systems and health care providers implement a new pathway for hospitalized patients with community-acquired pneumonia? 132
COPD and bronchiectasis: Phenotype, endotype or co-morbidity? 132
100 years of respiratory medicine: pneumonia 131
Impact of exacerbations in the natural course of COPD 131
Predicting Mycobacterium tuberculosis in patients with community-acquired pneumonia 130
Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis 130
Usefulness of simplified acute physiology score II in predicting mortality in patients admitted to an emergency medicine ward 129
Noninvasive ventilation or continuous positive airway pressure in pulmonary edema patients with respiratory acidosis? Look at the bicarbonates 129
The Clinical and Economic Impact of Exacerbations of Chronic Obstructive Pulmonary Disease: A Cohort of Hospitalized Patients 129
Geriatric multidimensional assessment for elderly patients with acute respiratory diseases 129
The bronchiectasis severity index. An international derivation and validation study 129
Thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumonia 127
Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy 127
Severe asthma exacerbation: role of acute Chlamydophila pneumoniae and Mycoplasma pneumoniae infection 126
Early application of non-invasive continuous positive airway pressure in acute respiratory distress syndrome due to a drug overdose: a case report 124
Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia 123
Validation of the 3CPO-score in a prospective cohort of Acute Cardiogenic Pulmonary Edema (ACPE) patients 123
Azithromycin and lower respiratory tract infections 122
Acidemia does not affect outcomes of patients with acute cardiogenic pulmonary edema treated with continuous positive airway pressure 122
Stratifying Risk Factors for Multidrug-Resistant Pathogens in Hospitalized Patients Coming From the Community With Pneumonia 122
International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia 122
Antibiotics as immunomodulant agents in COPD 121
Are multi-drug resistant (MDR) pathogens related to higher mortality in pneumonia? 121
Do prognostic factors help physicians in predicting legionellosis' respiratory complications? 121
The role of biomarkers in low respiratory tract infections 121
Clinical and economical impact of exacerbations of chronic obstructive pulmonary disease (COPD): a two year study 118
Low CURB-65 is of limited value in deciding discharge of patients with community-acquired pneumonia 117
Acute myocardial infarction versus other cardiovascular events in communityacquired pneumonia 117
Where are the acutely ill best cared for and who should look after them? 116
Pneumonia in the community caused by multidrug-resistant organisms: keep working on probabilistic scores 116
Pneumococcal Vaccine and Patients with Pulmonary Diseases 116
Individualizing duration of antibiotic therapy in community-acquired pneumonia 116
Nosocomial transmission of carbapenem-resistant Klebsiella pneumoniae in an Italian university hospital: a molecular epidemiological study 116
The management of patients with community-acquired pneumonia beyond antibiotic therapy 114
Acute exacerbation of COPD: application of evidence-based guidelines 114
Chlamydophila pneumoniae 112
Management of nontuberculous mycobacterial infection in the elderly 110
Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis in the protective versus deleterious inflammatory response in pneumonia 109
Cardiac diseases complicating community-acquired pneumonia 109
Incidence, etiology, timing, and risk factors for clinical failure in hospitalized patients with community-acquired pneumonia 107
Is it time for a "pneumo-geriatrician" for frail old patients with respiratory diseases? 106
Clinical Stability versus Clinical Failure in Patients with Community-Acquired Pneumonia 105
Chlamydia pneumoniae and Mycoplasma pneumoniae 104
Clinical applications of azithromycin microspheres in respiratory tract infections 104
Telithromycin in lower respiratory tract infections 103
Acute myocardial infarction in hospitalized patients with community-acquired pneumonia 103
The pneumonia severity index and the CRB-65 in cancer patients with community-acquired pneumonia 101
Highlights on the appropriate use of fluoroquinolones in respiratory tract infections 97
Association between time to clinical stability and outcomes after discharge in hospitalized patients with community-acquired pneumonia 97
Non-invasive-ventilation in H1N1 acute respiratory failure in emergency department: A case series 96
The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia 95
Healthcare-associated pneumonia: where do we go next? 93
Acute effects of positive end-expiratory pressure on left ventricle diastolic function in healthy subjects 92
Predicting mortality in hospitalized patients with 2009 H1N1 influenza pneumonia 92
Chlamydophila pneumoniae induces a sustained airway hyperresponsiveness and inflammation in mice 90
Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective 90
Helmet continuous positive airway pressure vs oxygen therapy to improve oxygenation in community-acquired pneumonia: a randomized, controlled trial 88
“Normotension” on admission to the emergency department affects outcome of patients with acute cardiogenic pulmonary edema (ACPE) 86
The changing microbiologic epidemiology of community-acquired pneumonia 84
Totale 13.447
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.561
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.561
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020869 0 0 0 0 0 0 0 220 288 118 175 68
2020/20211.586 134 84 165 168 108 82 145 139 146 219 69 127
2021/20221.059 51 102 104 90 52 103 55 61 64 86 93 198
2022/20231.833 250 532 224 133 92 315 9 90 133 4 25 26
2023/20241.249 35 32 47 31 172 335 254 57 153 15 10 108
2024/20251.188 205 348 76 141 275 60 82 1 0 0 0 0
Totale 14.210